Selected research
Industry Research
Chitosan Hemostatic Material Industry Research Report 2026
Market perspective
The global Chitosan Hemostatic Material market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Chitosan Hemostatic Material is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Chitosan Hemostatic Material is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Chitosan Hemostatic Material is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Chitosan Hemostatic Material include Lanhine Medical, Yancheng Yankang Medical Equipment, Shijiazhuang Yishengtang Medical Product, Success Bio-Tech, Biotemed, Haiyuan Hairun, Tricol Biomedical, Mermaid Medical and MedTrade Products, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Chitosan Hemostatic Material market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Chitosan Hemostatic Material Market by Company
Lanhine Medical
Yancheng Yankang Medical Equipment
Shijiazhuang Yishengtang Medical Product
Success Bio-Tech
Biotemed
Haiyuan Hairun
Tricol Biomedical
Mermaid Medical
MedTrade Products
Medcura
Hemostasis
Hemoflex
BioPharm Med
Anscare
Advamedica
Chitosan Hemostatic Material Segment by Type
Hemostatic Powder
Hemostatic Sponge
Hemostatic Gauze
Others
Chitosan Hemostatic Material Segment by Application
Surgery
First Aid
Chitosan Hemostatic Material Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chitosan Hemostatic Material market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Chitosan Hemostatic Material and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chitosan Hemostatic Material.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Chitosan Hemostatic Material manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Chitosan Hemostatic Material by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Chitosan Hemostatic Material in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Hemostatic Powder
- Hemostatic Sponge
- Hemostatic Gauze
- Others
Applications
- Surgery
- First Aid
Companies covered
- Lanhine Medical
- Yancheng Yankang Medical Equipment
- Shijiazhuang Yishengtang Medical Product
- Success Bio-Tech
- Biotemed
- Haiyuan Hairun
- Tricol Biomedical
- Mermaid Medical
- MedTrade Products
- Medcura
- Hemostasis
- Hemoflex
- BioPharm Med
- Anscare
- Advamedica
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Chitosan Hemostatic Material Market Size (2021-2032)
- 2.2.2 Global Chitosan Hemostatic Material Sales (2021-2032)
- 2.2.3 Global Chitosan Hemostatic Material Market Average Price (2021-2032)
- 2.3 Chitosan Hemostatic Material by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Hemostatic Powder
- 2.3.3 Hemostatic Sponge
- 2.3.4 Hemostatic Gauze
- 2.3.5 Others
- 2.4 Chitosan Hemostatic Material by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Surgery
- 2.4.3 First Aid
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Chitosan Hemostatic Material Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Chitosan Hemostatic Material Sales (Units) of Manufacturers (2021-2026)
- 3.3 Global Chitosan Hemostatic Material Revenue of Manufacturers (2021-2026)
- 3.4 Global Chitosan Hemostatic Material Average Price by Manufacturers (2021-2026)
- 3.5 Global Chitosan Hemostatic Material Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Chitosan Hemostatic Material, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Chitosan Hemostatic Material, Product Type & Application
- 3.8 Global Manufacturers of Chitosan Hemostatic Material, Established Date
- 3.9 Global Chitosan Hemostatic Material Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Lanhine Medical
- 4.1.1 Lanhine Medical Company Information
- 4.1.2 Lanhine Medical Business Overview
- 4.1.3 Lanhine Medical Chitosan Hemostatic Material Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Lanhine Medical Chitosan Hemostatic Material Product Portfolio
- 4.1.5 Lanhine Medical Recent Developments
- 4.2 Yancheng Yankang Medical Equipment
- 4.2.1 Yancheng Yankang Medical Equipment Company Information
- 4.2.2 Yancheng Yankang Medical Equipment Business Overview
- 4.2.3 Yancheng Yankang Medical Equipment Chitosan Hemostatic Material Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Yancheng Yankang Medical Equipment Chitosan Hemostatic Material Product Portfolio
- 4.2.5 Yancheng Yankang Medical Equipment Recent Developments
- 4.3 Shijiazhuang Yishengtang Medical Product
- 4.3.1 Shijiazhuang Yishengtang Medical Product Company Information
- 4.3.2 Shijiazhuang Yishengtang Medical Product Business Overview
- 4.3.3 Shijiazhuang Yishengtang Medical Product Chitosan Hemostatic Material Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Shijiazhuang Yishengtang Medical Product Chitosan Hemostatic Material Product Portfolio
- 4.3.5 Shijiazhuang Yishengtang Medical Product Recent Developments
- 4.4 Success Bio-Tech
- 4.4.1 Success Bio-Tech Company Information
- 4.4.2 Success Bio-Tech Business Overview
- 4.4.3 Success Bio-Tech Chitosan Hemostatic Material Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Success Bio-Tech Chitosan Hemostatic Material Product Portfolio
- 4.4.5 Success Bio-Tech Recent Developments
- 4.5 Biotemed
- 4.5.1 Biotemed Company Information
- 4.5.2 Biotemed Business Overview
- 4.5.3 Biotemed Chitosan Hemostatic Material Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Biotemed Chitosan Hemostatic Material Product Portfolio
- 4.5.5 Biotemed Recent Developments
- 4.6 Haiyuan Hairun
- 4.6.1 Haiyuan Hairun Company Information
- 4.6.2 Haiyuan Hairun Business Overview
- 4.6.3 Haiyuan Hairun Chitosan Hemostatic Material Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Haiyuan Hairun Chitosan Hemostatic Material Product Portfolio
- 4.6.5 Haiyuan Hairun Recent Developments
- 4.7 Tricol Biomedical
- 4.7.1 Tricol Biomedical Company Information
- 4.7.2 Tricol Biomedical Business Overview
- 4.7.3 Tricol Biomedical Chitosan Hemostatic Material Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Tricol Biomedical Chitosan Hemostatic Material Product Portfolio
- 4.7.5 Tricol Biomedical Recent Developments
- 4.8 Mermaid Medical
- 4.8.1 Mermaid Medical Company Information
- 4.8.2 Mermaid Medical Business Overview
- 4.8.3 Mermaid Medical Chitosan Hemostatic Material Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Mermaid Medical Chitosan Hemostatic Material Product Portfolio
- 4.8.5 Mermaid Medical Recent Developments
- 4.9 MedTrade Products
- 4.9.1 MedTrade Products Company Information
- 4.9.2 MedTrade Products Business Overview
- 4.9.3 MedTrade Products Chitosan Hemostatic Material Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 MedTrade Products Chitosan Hemostatic Material Product Portfolio
- 4.9.5 MedTrade Products Recent Developments
- 4.10 Medcura
- 4.10.1 Medcura Company Information
- 4.10.2 Medcura Business Overview
- 4.10.3 Medcura Chitosan Hemostatic Material Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Medcura Chitosan Hemostatic Material Product Portfolio
- 4.10.5 Medcura Recent Developments
- 4.11 Hemostasis
- 4.11.1 Hemostasis Company Information
- 4.11.2 Hemostasis Business Overview
- 4.11.3 Hemostasis Chitosan Hemostatic Material Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Hemostasis Chitosan Hemostatic Material Product Portfolio
- 4.11.5 Hemostasis Recent Developments
- 4.12 Hemoflex
- 4.12.1 Hemoflex Company Information
- 4.12.2 Hemoflex Business Overview
- 4.12.3 Hemoflex Chitosan Hemostatic Material Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Hemoflex Chitosan Hemostatic Material Product Portfolio
- 4.12.5 Hemoflex Recent Developments
- 4.13 BioPharm Med
- 4.13.1 BioPharm Med Company Information
- 4.13.2 BioPharm Med Business Overview
- 4.13.3 BioPharm Med Chitosan Hemostatic Material Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 BioPharm Med Chitosan Hemostatic Material Product Portfolio
- 4.13.5 BioPharm Med Recent Developments
- 4.14 Anscare
- 4.14.1 Anscare Company Information
- 4.14.2 Anscare Business Overview
- 4.14.3 Anscare Chitosan Hemostatic Material Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Anscare Chitosan Hemostatic Material Product Portfolio
- 4.14.5 Anscare Recent Developments
- 4.15 Advamedica
- 4.15.1 Advamedica Company Information
- 4.15.2 Advamedica Business Overview
- 4.15.3 Advamedica Chitosan Hemostatic Material Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Advamedica Chitosan Hemostatic Material Product Portfolio
- 4.15.5 Advamedica Recent Developments
5 Global Chitosan Hemostatic Material Market Scenario by Region
- 5.1 Global Chitosan Hemostatic Material Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Chitosan Hemostatic Material Sales by Region: 2021-2032
- 5.2.1 Global Chitosan Hemostatic Material Sales by Region: 2021-2026
- 5.2.2 Global Chitosan Hemostatic Material Sales by Region: 2027-2032
- 5.3 Global Chitosan Hemostatic Material Revenue by Region: 2021-2032
- 5.3.1 Global Chitosan Hemostatic Material Revenue by Region: 2021-2026
- 5.3.2 Global Chitosan Hemostatic Material Revenue by Region: 2027-2032
- 5.4 North America Chitosan Hemostatic Material Market Facts & Figures by Country
- 5.4.1 North America Chitosan Hemostatic Material Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Chitosan Hemostatic Material Sales by Country (2021-2032)
- 5.4.3 North America Chitosan Hemostatic Material Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Chitosan Hemostatic Material Market Facts & Figures by Country
- 5.5.1 Europe Chitosan Hemostatic Material Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Chitosan Hemostatic Material Sales by Country (2021-2032)
- 5.5.3 Europe Chitosan Hemostatic Material Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Chitosan Hemostatic Material Market Facts & Figures by Country
- 5.6.1 Asia Pacific Chitosan Hemostatic Material Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Chitosan Hemostatic Material Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Chitosan Hemostatic Material Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Chitosan Hemostatic Material Market Facts & Figures by Country
- 5.7.1 South America Chitosan Hemostatic Material Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Chitosan Hemostatic Material Sales by Country (2021-2032)
- 5.7.3 South America Chitosan Hemostatic Material Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Chitosan Hemostatic Material Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Chitosan Hemostatic Material Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Chitosan Hemostatic Material Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Chitosan Hemostatic Material Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Chitosan Hemostatic Material Sales by Type (2021-2032)
- 6.1.1 Global Chitosan Hemostatic Material Sales by Type (2021-2032) & (Units)
- 6.1.2 Global Chitosan Hemostatic Material Sales Market Share by Type (2021-2032)
- 6.2 Global Chitosan Hemostatic Material Revenue by Type (2021-2032)
- 6.2.1 Global Chitosan Hemostatic Material Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Chitosan Hemostatic Material Revenue Market Share by Type (2021-2032)
- 6.3 Global Chitosan Hemostatic Material Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Chitosan Hemostatic Material Sales by Application (2021-2032)
- 7.1.1 Global Chitosan Hemostatic Material Sales by Application (2021-2032) & (Units)
- 7.1.2 Global Chitosan Hemostatic Material Sales Market Share by Application (2021-2032)
- 7.2 Global Chitosan Hemostatic Material Revenue by Application (2021-2032)
- 7.2.1 Global Chitosan Hemostatic Material Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Chitosan Hemostatic Material Revenue Market Share by Application (2021-2032)
- 7.3 Global Chitosan Hemostatic Material Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Chitosan Hemostatic Material Value Chain Analysis
- 8.1.1 Chitosan Hemostatic Material Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Chitosan Hemostatic Material Production Mode & Process
- 8.2 Chitosan Hemostatic Material Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Chitosan Hemostatic Material Distributors
- 8.2.3 Chitosan Hemostatic Material Customers
9 Global Chitosan Hemostatic Material Analyzing Market Dynamics
- 9.1 Chitosan Hemostatic Material Industry Trends
- 9.2 Chitosan Hemostatic Material Industry Drivers
- 9.3 Chitosan Hemostatic Material Industry Opportunities and Challenges
- 9.4 Chitosan Hemostatic Material Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst